Daniel J. Mitchell

Insider Reports History

Entity
Individual
Signature
/s/ C. Jeffrey Dekker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel J. Mitchell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARCA biopharma, Inc. Director Common Stock 611 $1.53K $2.50 Jan 30, 2024 Direct
ARCA biopharma, Inc. Director Stock Option (right to buy) 6K Jan 30, 2024 Direct

Insider Reports Filed by Daniel J. Mitchell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABIO ARCA biopharma, Inc. Jan 30, 2024 1 $0 4 Jan 31, 2024 Director
ABIO ARCA biopharma, Inc. Dec 15, 2022 1 $0 4 Dec 19, 2022 Director